Literature DB >> 29532936

Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai-Barrow syndrome.

F Anglani1, L Terrin1, M Brugnara2, M Battista3, V Cantaluppi3, M Ceol1, L Bertoldi4, G Valle4, M P Joy5, B R Pober5, M Longoni5.   

Abstract

Whole exome sequencing detected novel likely pathogenic variants in LRP2 gene in 2 patients presenting with hearing and vision loss, and the Dent disease (DD) classical renal phenotype, that is, low molecular weight proteinuria (LMWP), hypercalciuria and nephrocalcinosis/nephrolithiasis. We propose that a subset of patients presenting as DD may represent unrecognized cases or mild forms of Donnai-Barrow/facio-oculo-acustico-renal (DB/FOAR) syndrome or be on the phenotypic continuum between the 2 conditions.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29532936      PMCID: PMC5995642          DOI: 10.1111/cge.13242

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction.

Authors:  Angélique Dachy; François Paquot; Guillaume Debray; Christophe Bovy; Erik I Christensen; Laure Collard; François Jouret
Journal:  Pediatr Nephrol       Date:  2015-03-31       Impact factor: 3.714

Review 2.  Dent's disease.

Authors:  Olivier Devuyst; Rajesh V Thakker
Journal:  Orphanet J Rare Dis       Date:  2010-10-14       Impact factor: 4.123

Review 3.  A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis.

Authors:  Barbara R Pober; Mauro Longoni; Kristin M Noonan
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-01

4.  Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients.

Authors:  Caroline M Gorvin; Martijn J Wilmer; Sian E Piret; Brian Harding; Lambertus P van den Heuvel; Oliver Wrong; Parmjit S Jat; Jonathan D Lippiat; Elena N Levtchenko; Rajesh V Thakker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-09       Impact factor: 11.205

  4 in total
  5 in total

1.  Spectrum of tubular dysfunction in Donnai-Barrow syndrome. Lessons for the clinical nephrologist.

Authors:  Marina Aksenova; Natalia Zaikova; Tatiana Lepaeva
Journal:  J Nephrol       Date:  2021-01-20       Impact factor: 3.902

2.  Beyond the tubule: pathological variants of LRP2, encoding the megalin receptor, result in glomerular loss and early progressive chronic kidney disease.

Authors:  Jennifer R Charlton; Weizhen Tan; Ghaleb Daouk; Lisa Teot; Seymour Rosen; Kevin M Bennett; Aleksandra Cwiek; Sejin Nam; Francesco Emma; François Jouret; João Paulo Oliveira; Lisbeth Tranebjærg; Carina Frykholm; Shrikant Mane; Friedhelm Hildebrandt; Tarak Srivastava; Tina Storm; Erik Ilsø Christensen; Rikke Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-26

3.  Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome.

Authors:  Julia Flemming; Maike Marczenke; Ina-Maria Rudolph; Rikke Nielsen; Tina Storm; Ilsoe Christensen Erik; Sebastian Diecke; Francesco Emma; Thomas E Willnow
Journal:  Kidney Int       Date:  2020-03-24       Impact factor: 10.612

4.  Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biopsies.

Authors:  Lisa Gianesello; Monica Ceol; Loris Bertoldi; Liliana Terrin; Giovanna Priante; Luisa Murer; Licia Peruzzi; Mario Giordano; Fabio Paglialonga; Vincenzo Cantaluppi; Claudio Musetti; Giorgio Valle; Dorella Del Prete; Franca Anglani; Dent Disease Italian Network
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

Review 5.  Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon.

Authors:  Lisa Gianesello; Dorella Del Prete; Franca Anglani; Lorenzo A Calò
Journal:  Hum Genet       Date:  2020-08-29       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.